Switch to:
Johnson & Johnson  (NYSE:JNJ) Research & Development: $9,163 Mil (TTM As of Jun. 2017)

This is the expense the company spent on research and development. Johnson & Johnson's research and development for the three months ended in Jun. 2017 was $2,285 Mil. Its research and development for the trailing twelve months (TTM) ended in Jun. 2017 was $9,163 Mil.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Johnson & Johnson Annual Data

Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Research & Development Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,828.00 8,183.00 8,494.00 9,046.00 9,095.00

Johnson & Johnson Quarterly Data

Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Research & Development Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,293.00 2,178.00 2,640.00 2,060.00 2,285.00

Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2017 was 2178 (Sep. 2016 ) + 2640 (Dec. 2016 ) + 2060 (Mar. 2017 ) + 2285 (Jun. 2017 ) = $9,163 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms


Headlines

From the Internet

JNJ
Dow ETFs Soar as the Index Hits 23,000

- Zacks 2017-10-18 15:19:00

JNJ
Impact Fasbs Pension Cost Accounting Rule Change

- Seekingalpha 2017-10-18 12:00:16

JNJ
16 61 Safer Dividend Healthcare Dogs October

- Seekingalpha 2017-10-18 11:23:24

JNJ
Johnson And Johnson Time Highs Time Sell Buy

- Seekingalpha 2017-10-18 10:25:06

JNJ
Stock Market News For Oct 18, 2017

- Zacks 2017-10-18 09:44:00

JNJ
Johnson And Johnson One Time Bumps

- Seekingalpha 2017-10-18 08:48:32

JNJ
Johnson And Johnson Q3 Beat Low Quality

- Seekingalpha 2017-10-18 08:22:59

JNJ
Markets May Cheaper Think Cramers Mad Money 10 17 17

- Seekingalpha 2017-10-18 07:39:22

JNJ
Johnson And Johnson Unsinkable

- Seekingalpha 2017-10-18 07:25:07

JNJ
Johnson And Johnson Amazing Company Something Wrong

- Seekingalpha 2017-10-17 23:17:11

JNJ
What Happened in the Stock Market Today

- Fool 2017-10-17 17:12:00

JNJ
Johnson & Johnson Jumps on Pharma Strength

- Fool 2017-10-17 13:18:00

JNJ
Why TransEnterix Stock Is Soaring Today

- Fool 2017-10-17 12:39:00

JNJ
J&J: Strong Earnings Is the Best Medicine

- Barron's 2017-10-17 10:13:00

JNJ
U.S. stocks open flat despite strong bank earnings

- MarketWatch 2017-10-17 09:33:00

JNJ
Market: Spectacular All Around

- Zacks 2017-10-17 09:20:00

JNJ
Wall Street Breakfast Dow Earnings Focus Amid Records

- Seekingalpha 2017-10-17 06:59:17

JNJ
5 Earnings All Stars to Start Off the Week

- Zacks 2017-10-16 17:33:00

JNJ
Take Profits Johnson And Johnson

- Seekingalpha 2017-10-16 17:24:02

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK